KMC Speciality net profit up 120% in Q1FY26 to ₹165.7 million

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

KMC Speciality Hospitals posted strong Q1FY26 standalone results with net profit surging 120% YoY to ₹165.7 million. Revenue grew 38% to ₹917.8 million, supported by a 700 bps expansion in EBITDA margins to 31%. The results were approved by the Board on August 14, 2026.

powered bylight_fuzz_icon
48233349

*this image is generated using AI for illustrative purposes only.

KMC Speciality Hospitals reported a sharp rise in profitability for the first quarter of FY26, with standalone net profit jumping to ₹165.7 million compared to ₹75.4 million in the same period last year. The healthcare provider also saw its top-line growth accelerate, logging revenue from operations of ₹917.8 million against ₹665.5 million year-on-year.

The company’s operational efficiency improved notably during the period. EBITDA stood at ₹284.3 million, up from ₹163.9 million previously. This expansion was accompanied by a widening of the EBITDA margin to 31%, an increase from 24% in the prior year. The Board of Directors approved the unaudited financial results on August 14, 2026, following a limited review by statutory auditors Deloitte Haskins & Sells.

Financial Performance

Metric: Q1FY26 Q1FY25 Change
Revenue from operations: ₹917.8 million ₹665.5 million +38.0%
EBITDA: ₹284.3 million ₹163.9 million +73.5%
EBITDA Margin: 31% 24% +700 bps
Net Profit: ₹165.7 million ₹75.4 million +120.0%

What the Numbers Show

The divergence between revenue growth and profit growth highlights significant operating leverage. While revenue increased by approximately 38%, net profit more than doubled, rising by over 120%. This suggests that the additional revenue generated contributed disproportionately to the bottom line, likely due to fixed cost absorption or improved pricing power, as evidenced by the 700 basis point expansion in EBITDA margins.

Historical Stock Returns for KMC Speciality Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.70%-2.03%-2.03%-2.03%-2.03%-2.03%

Will KMC Speciality Hospitals be able to sustain the 31% EBITDA margin expansion in subsequent quarters as revenue scales further?

How does this surge in profitability impact KMC's valuation multiples compared to its listed peers in the Indian healthcare sector?

What specific operational levers or cost-saving measures drove the 700 basis point margin improvement, and are these trends repeatable?

KMC Speciality Hospitals
View Company Insights
View All News
like20
dislike

KMC Speciality Hospitals sees indirect pledge on 46.93% of promoter stake

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Promoter shareholders of SKMCIL, the 75% stakeholder in KMC Speciality Hospitals, have pledged 14.53% and placed a non-disposal undertaking on 32.40% of their shares. This creates an indirect encumbrance over 46.93% of the holding company's stake, securing debentures issued by Prospera Healthcorp Private Limited.

powered bylight_fuzz_icon
48058773

*this image is generated using AI for illustrative purposes only.

kmc speciality hospitals has disclosed an indirect encumbrance over its promoter group’s shareholding following a pledge and non-disposal undertaking by certain promoter shareholders of its holding company, Sri Kauvery Medical Care (India) Limited (SKMCIL). The move secures non-convertible debentures issued by Prospera Healthcorp Private Limited, impacting the effective control structure of the listed hospital chain without any direct transfer of voting rights in the target company.

The disclosure was filed with BSE Limited on August 11, 2026, pursuant to Regulation 29(1) read with Regulation 29(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Catalyst Trusteeship Limited, acting as the Debenture Trustee for Prospera Healthcorp Private Limited, made the filing on behalf of the debenture holders. The encumbrance arises indirectly because SKMCIL holds 75% of the issued and paid-up share capital of KMC Speciality Hospitals (India) Limited.

Details of Encumbrance

The indirect encumbrance comprises two distinct components created over the equity shares of SKMCIL in favor of the Debenture Trustee:

Encumbrance Type Shares Affected Percentage of SKMCIL Shareholding
Pledge 74,10,831 14.53%
Non-Disposal Undertaking 1,65,32,316 32.40%
Total Encumbrance 2,39,43,147 46.93%

SKMCIL holds 12,23,13,750 equity shares in KMC Speciality Hospitals (India) Limited, constituting 75% of the listed entity’s total equity share capital of INR 16,30,85,000. The total diluted share/voting capital of the target company remains unchanged at INR 16,30,85,000.

Timeline and Regulatory Framework

The underlying agreements were executed in early July 2026. The Debenture Trust Deed between Prospera Healthcorp Private Limited and Catalyst Trusteeship Limited was dated July 6, 2026. The unattested Share Pledge Agreement was executed on July 7, 2026, while the Non-Disposal Undertakings were provided on July 6, 2026.

Catalyst Trusteeship Limited confirmed the creation of the entire encumbrance on August 7, 2026, coinciding with the allotment of the debentures by the issuer. The filing clarifies that the acquirer, represented by the Debenture Trustee, does not hold any direct shares or voting rights in KMC Speciality Hospitals (India) Limited prior to or after this transaction. The encumbrance is strictly limited to the shares of the holding company, SKMCIL.

What This Means for Shareholders

While the pledge and non-disposal undertaking do not result in a direct change of ownership or voting rights at the listed level, they create a security interest for the debenture holders of Prospera Healthcorp Private Limited. In the event of default on the debentures, the trustee may invoke these rights over the holding company’s stake, which could indirectly influence the control and management of KMC Speciality Hospitals (India) Limited. Investors should monitor subsequent filings for any changes in the promoter group’s effective control or further disclosures related to the debt obligations.

Historical Stock Returns for KMC Speciality Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.70%-2.03%-2.03%-2.03%-2.03%-2.03%

What are the specific maturity dates and interest rates of the non-convertible debentures issued by Prospera Healthcorp that triggered this pledge?

How might the 32.40% non-disposal undertaking restrict the promoter group's ability to raise additional capital or restructure debt in the near future?

Could this indirect encumbrance impact KMC Speciality Hospitals' credit ratings or its ability to secure independent financing for expansion projects?

KMC Speciality Hospitals
View Company Insights
View All News
like15
dislike

More News on KMC Speciality Hospitals

1 Year Returns:-2.03%